NCT01167959

Brief Summary

The purpose of this study is to determine the effect of gastric banding or gastric bypass on hypothalamic morphology and function, gut hormones and systems biology in obese subjects with and without type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 21, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 22, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

December 24, 2012

Status Verified

December 1, 2012

Enrollment Period

1.7 years

First QC Date

July 21, 2010

Last Update Submit

December 20, 2012

Conditions

Keywords

ObesityDiabetesBariatric surgery

Outcome Measures

Primary Outcomes (1)

  • Changes in gut hormones

    3 weeks

Study Arms (1)

obesity diabetes, surgical and dietary

Procedure: Roux en Y gastric bypass and lap. gastric bandingBehavioral: Prodimed dietary intervention

Interventions

Standard RYGB and LAGB procedures

obesity diabetes, surgical and dietary

3 months of using the prodimed diet

obesity diabetes, surgical and dietary

Eligibility Criteria

Age35 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Obese (type 2 diabetic or not) population from primary care (dietary intervention) and hospital setting (bariatric surgery)

You may qualify if:

  • Patients aged 35-65 years;
  • BMI \> 40 kg/m2;
  • BMI \> 35 and \<40 kg/m2 with co-morbidity, which is expected to improve after surgically-induced weight loss;
  • A history of longstanding obesity (\>5 years);
  • Proven failed attempts to lose weight in a conventional way, or primarily successful weight loss with eventual weight regain;
  • Intention to adhere to a postoperative follow-up programme.

You may not qualify if:

  • BMI\> 50 or body weight \> 150 kg (because it is impossible to safely put people above this weight on a standard table for MRI);
  • Subjects with disease related obesity, i.e. Cushing or medication related obesity;
  • Use of medication known to affect glucose or lipid metabolism (i.e. prednisone)
  • Monogenetic diabetes: MODY, Mitochondrial diabetes;
  • LADA (adult-onset latent autoimmune diabetes); detected by c-peptide measurement on screening.
  • Impaired renal function (serum creatinine \> 176 μmol/L);
  • Leg ulcers, gangrene.
  • Any genetic or psychiatric disease (e.g. fragile X syndrome, major depression) affecting the brain
  • Any significant chronic disease
  • Renal or hepatic disease
  • Pregnancy
  • Recent weight changes or attempts to loose weight (\> 3 kg weight gain or loss, within the last 3 months)
  • Aerobic exercise more that 3 times 60 minutes a week
  • Alcohol consumption of more than 28 units per week at present or in the past
  • Recent blood donation (within the last 2 months)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leiden University Medical Centre

Leiden, South Holland, 2333 ZA, Netherlands

Location

Related Publications (4)

  • Maessen DE, Hanssen NM, Lips MA, Scheijen JL, Willems van Dijk K, Pijl H, Stehouwer CD, Schalkwijk CG. Energy restriction and Roux-en-Y gastric bypass reduce postprandial alpha-dicarbonyl stress in obese women with type 2 diabetes. Diabetologia. 2016 Sep;59(9):2013-7. doi: 10.1007/s00125-016-4009-1. Epub 2016 Jun 16.

  • Lips MA, Van Klinken JB, van Harmelen V, Dharuri HK, 't Hoen PA, Laros JF, van Ommen GJ, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, Dane A, Harms A, Vreeken R, Hankemeier T, Smit JW, Pijl H, Willems van Dijk K. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes. Diabetes Care. 2014 Dec;37(12):3150-6. doi: 10.2337/dc14-0195. Epub 2014 Oct 14.

  • Lips MA, Wijngaarden MA, van der Grond J, van Buchem MA, de Groot GH, Rombouts SA, Pijl H, Veer IM. Resting-state functional connectivity of brain regions involved in cognitive control, motivation, and reward is enhanced in obese females. Am J Clin Nutr. 2014 Aug;100(2):524-31. doi: 10.3945/ajcn.113.080671. Epub 2014 Jun 25.

  • Lips MA, Pijl H, van Klinken JB, de Groot GH, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, Smit JW. Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects. Eur J Endocrinol. 2013 Aug 28;169(3):339-47. doi: 10.1530/EJE-13-0339. Print 2013 Sep.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood/Sera Adipose tissue biopsies

MeSH Terms

Conditions

ObesityDiabetes Mellitus

Interventions

Gastric Bypass

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Bariatric SurgeryBariatricsObesity ManagementTherapeuticsGastroenterostomyAnastomosis, SurgicalSurgical Procedures, OperativeDigestive System Surgical Procedures

Study Officials

  • Hanno Pijl, MD Phd Proff

    Leiden University Medical Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
drs

Study Record Dates

First Submitted

July 21, 2010

First Posted

July 22, 2010

Study Start

June 1, 2009

Primary Completion

February 1, 2011

Study Completion

May 1, 2012

Last Updated

December 24, 2012

Record last verified: 2012-12

Locations